Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!
IRVINE, Calif., July 18, 2013 (GLOBE NEWSWIRE) -- Endologix, Inc. (Nasdaq:ELGX), developer and marketer of minimally invasive treatments for aortic disorders, announced today details relating to the release of its second quarter 2013 financial results, which will take place on Tuesday, July 30, 2013 after the close of the market.
Help employers find you! Check out all the jobs and post your resume.
